Sunday, July 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 63 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 9422245

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted

  2. US 9415116

    Compositions and methods for delivering inhibitory oligonucleotides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 16, 2016 · Expires Aug 11, 2036

    granted

  3. US 9415105

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 16, 2016 · Expires Aug 11, 2036

    granted

  4. US 9416139

    Spiro ring compound as hepatitis C virus (HCV) inhibitor and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Aug 16, 2016 · Expires Aug 11, 2036

    granted

  5. US 9416165

    Methods of inhibiting viral replication and improving T cell function employing soluble Tim-3 inhibitors

    The Regents of the University of California · Granted Aug 16, 2016 · Expires Aug 11, 2036

    granted

  6. US 9408813

    Small-molecule inhibitors of dengue virus proteases

    The Board of Regents of the University of Texas System · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted

  7. US 9408829

    Inhibitors of CD40-TRAF6 interaction

    Ludwig-Maximilians-Universitat Munchen · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted

  8. US 9403856

    Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted

  9. US 9403819

    Apoptosis signal-regulating kinase 1 inhibitors

    Takeda Pharmaceutical Company Limited · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted

  10. US 9399627

    Substituted macrocyclic compounds having proteasome inhibitory activity

    The Regents of the University of California · Granted Jul 26, 2016 · Expires Jul 21, 2036

    granted

  11. US 9394303

    Small molecule inhibitors of MCL-1 and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  12. US 9393245

    Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors

    VTV THERAPEUTICS LLC · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  13. US 9394302

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  14. US 9394316

    Inhibitors of the plasmodial surface anion channel as antimalarials

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  15. US 9388145

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  16. US 9387205

    Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

    TAKEDA GMBH · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  17. US 9388189

    Pyrrolotriazinone derivatives as PI3K inhibitors

    Almirall, S.A. · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  18. US 9388408

    Oligonucleotide-based inhibitors comprising locked nucleic acid motif

    MIRAGEN THERAPEUTICS, INC. · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  19. US 9382213

    Heterocyclic and cyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase

    UNIVERSITY OF CONNECTICUT · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted

  20. US 9382256

    Formulation of Syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted

  21. US 9376448

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted

  22. US 9375402

    Oral formulations of kinase inhibitors

    VERASTEM, INC. · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted

  23. US 9375438

    Inhibitors of NCCa-ATP channels for therapy

    The United States of America as Represented by the Dept. of Veterans Affairs · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted

  24. US 9370505

    Pharmaceutical compositions comprising an aromatse inhibitors

    MEREO BIOPHARMA 2 LIMITED · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.